Immunotherapy could be used to treat depression, early trial suggests

UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patients

Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial.

Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression.